2013Chinese and Foreign Medical ResearchRequires access

The Clinical Efficacy Comparation of Heluo Shugan Capsule and Salvia Miltiorrhiza Tablet in the Liver Fibrosis

Fan Ni

Open publisher page 0 citations

Abstract

Objective:To investigate the clinical efficacy of Heluo Shugan capsule and salvia miltiorrhiza tablet in the liver fibrosis.Methods:140 cases of liver fibrosis caused by hepatitis B were randomly divided into two groups,salvia miltiorrhiza group and Heluo Shugan capsule group.Liver function and liver fibrosis were tested respectively before and after therapy.Results:The liver function and liver fibrosis had been improved obviously after therapy.The difference of serological LN and C-Ⅳ after therapy were statistically significant in two groups(P0.05).Conclusion:Both Heluo Shugan capsule and salvia miltiorrhiza tablet could improve liver fibrosis.Heluo Shugan capsule is superior to salvia miltiorrhiza tablet in LN and C-Ⅳ.

About this research paper

What this paper is about

Objective:To investigate the clinical efficacy of Heluo Shugan capsule and salvia miltiorrhiza tablet in the liver fibrosis.Methods:140 cases of liver fibrosis caused by hepatitis B were randomly divided into two groups,salvia miltiorrhiza group and Heluo Shugan capsule group.Liver function and liver fibrosis were tested respectively before and after therapy.Results:The liver function and liver fibrosis had been improved obviously after therapy.The difference of serological LN and C-Ⅳ after therapy were statistically significant in two groups(P0.05).Conclusion:Both Heluo Shugan capsule and salvia miltiorrhiza tablet could improve liver fibrosis.Heluo Shugan capsule is superior to salvia miltiorrhiza tablet in LN and C-Ⅳ.

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Objective:To investigate the clinical efficacy of Heluo Shugan capsule and salvia miltiorrhiza tablet in the liver fibrosis.Methods:140 cases of liver fibrosis caused by hepatitis B were randomly divided into two groups,salvia miltiorrhiza group and Heluo Shugan capsule group.Liver function and liver fibrosis were tested respectively before and after therapy.Results:The liver function and liver fibrosis had been improved obviously after therapy.The difference of serological LN and C-Ⅳ after therapy were statistically significant in two groups(P0.05).Conclusion:Both Heluo Shugan capsule and salvia miltiorrhiza tablet could improve liver fibrosis.Heluo Shugan capsule is superior to salvia miltiorrhiza tablet in LN and C-Ⅳ.

Key concepts: Salvia miltiorrhiza, Medicine, Capsule, Liver function, Fibrosis, Traditional medicine, Gastroenterology, Liver fibrosis

Related papers

Back to paper searchBrowse research topicsOriginal source
The Clinical Efficacy Comparation of Heluo Shugan Capsule and Salvia Miltiorrhiza Tablet in the Liver Fibrosis — Research Paper | ScholarLens